by Bibianna Purgina MD FRCPC and Jason Wasserman MD PhD FRCPC
October 28, 2022
Chondroblastic osteosarcoma is a type of bone cancer. This type of cancer can start in any bone in the body, however, most are found in the long bones of the arms and legs. The jaws are also commonly involved. This type of cancer affects both children and older adults.
Chondroblastic means that some areas of the tumour have changed to look like a type of connective tissue called cartilage. The cartilage found in chondroblastic osteosarcoma is called “neoplastic” or “malignant” because it is made by the tumour cells.
For most patients who develop chondroblastic osteosarcoma, the cause remains unknown. However, some genetic syndromes such as Li-Fraumeni syndrome, hereditary retinoblastoma, and Bloom syndrome, increase the risk of developing chondroblastic osteosarcoma.
Symptoms of chondroblastic osteosarcoma include a rapidly enlarging and painful mass. As the tumour grows it can cause the bone to fracture (break).
The diagnosis of chondroblastic osteosarcoma is typically made after a small tissue sample has been removed in a procedure called a biopsy. After the diagnosis, most patients are treated first with chemotherapy and then with surgery. During surgery, the tumour is removed completely as a resection. The resection specimen is sent to a pathologist for examination. Your pathologist will examine the tumour under the microscope and give your surgeon and oncologist important information that will help guide your treatment.
All chondroblastic osteosarcomas are considered grade 3 or high-grade tumours. High-grade tumours are aggressive cancers that grow quickly and metastasize (spread) to other parts of the body.
Pathologists use the term extraosseous extension to describe a bone tumour that has broken through the outside surface of the bone and has spread into the surrounding tissue such as muscles, tendons, or the space around a joint. Extraosseous extension is important because it is associated with a worse prognosis.
Some bones are made up of multiple parts. If the tumour has grown from one part of a bone into another, your report will describe the tumour as invading adjacent bones. This is particularly important for tumours in the spine or pelvis because both of these bones are made up of multiple parts. Invasion of adjacent bones is important because it is associated with a worse prognosis. It also increases the pathologic tumour stage.
If you received chemotherapy before surgery, your pathologist will examine all the tissue sent to pathology to see how much of the tumour is still viable (alive). This is called the treatment effect. Pathologists often measure the treatment effect as the percentage of the tumour that appears dead when examined under the microscope. For example, if the tumour shows a 65% response to therapy, it means that 65% of the tumour is dead. Typically, chondroblastic osteosarcoma showing 90% or more response to therapy (meaning 90% of the tumour is dead and 10% or less of the tumour is still alive) is associated with a better prognosis.
Perineural invasion is a term pathologists use to describe cancer cells attached to or inside a nerve. A similar term, intraneural invasion, is used to describe cancer cells inside a nerve. Nerves are like long wires made up of groups of cells called neurons. Nerves are found all over the body and they are responsible for sending information (such as temperature, pressure, and pain) between your body and your brain. Perineural invasion is important because the cancer cells can use the nerve to spread into surrounding organs and tissues. This increases the risk that the tumour will regrow after surgery. If perineural invasion is seen, it will be included in your report. However, it is rare for perineural invasion to be found in chondroblastic osteosarcoma.
Lymphovascular invasion means that cancer cells were seen inside a blood vessel or lymphatic vessel. Blood vessels are long thin tubes that carry blood around the body. Lymphatic vessels are similar to small blood vessels except that they carry a fluid called lymph instead of blood. The lymphatic vessels connect with small immune organs called lymph nodes that are found throughout the body. Lymphovascular invasion is important because cancer cells can use blood vessels or lymphatic vessels to spread to other parts of the body such as lymph nodes or the lungs. If lymphovascular invasion is seen, it will be included in your report. However, it is rare for lymphovascular invasion to be found in chondroblastic osteosarcoma.
In pathology, a margin is the edge of a tissue that is cut when removing a tumour from the body. The margins described in a pathology report are very important because they tell you if the entire tumour was removed or if some of the tumour was left behind. The margin status will determine what (if any) additional treatment you may require.
Most pathology reports only describe margins after a surgical procedure called an excision or resection has been performed for the purpose of removing the entire tumour. For this reason, margins are not usually described after a procedure called a biopsy is performed for the purpose of removing only part of the tumour. The number of margins described in a pathology report depends on the types of tissues removed and the location of the tumour. The size of the margin (the amount of normal tissue between the tumour and the cut edge) also depends on the type of tumour being removed and the location of the tumour.
Pathologists carefully examine the margins to look for tumour cells at the cut edge of the tissue. If tumour cells are seen at the cut edge of the tissue, the margin will be described as positive. If no tumour cells are seen at the cut edge of the tissue, a margin will be described as negative. Even if all of the margins are negative, some pathology reports will also provide a measurement of the closest tumour cells to the cut edge of the tissue.
A positive (or very close) margin is important because it means that tumour cells may have been left behind in your body when the tumour was surgically removed. For this reason, patients who have a positive margin may be offered another surgery to remove the rest of the tumour or radiation therapy to the area of the body with the positive margin. The decision to offer additional treatment and the type of treatment options offered will depend on a variety of factors including the type of tumour removed and the area of the body involved. For example, additional treatment may not be necessary for a benign (non-cancerous) type of tumour but may be strongly advised for a malignant (cancerous) type of tumour.
Common margins for chondroblastic osteosarcoma include:
Lymph nodes are small immune organs found throughout the body. Cancer cells can spread from a tumour to lymph nodes through small vessels called lymphatics. The cancer cells in chondroblastic osteosarcoma typically do not spread to lymph nodes and for this reason, lymph nodes are not always removed at the same time as the tumour. However, when lymph nodes are removed, they will be examined under a microscope and the results will be described in your report.
Cancer cells typically spread first to lymph nodes close to the tumour although lymph nodes far away from the tumour can also be involved. For this reason, the first lymph nodes removed are usually close to the tumour. Lymph nodes further away from the tumour are only typically removed if they are enlarged and there is a high clinical suspicion that there may be cancer cells in the lymph node. Most reports will include the total number of lymph nodes examined, where in the body the lymph nodes were found, and the number (if any) that contain cancer cells. If cancer cells were seen in a lymph node, the size of the largest group of cancer cells (often described as “focus” or “deposit”) will also be included.
The examination of lymph nodes is important for two reasons. First, this information is used to determine the pathologic nodal stage (pN). Second, finding cancer cells in a lymph node increases the risk that cancer cells will be found in other parts of the body in the future. As a result, your doctor will use this information when deciding if additional treatment such as chemotherapy, radiation therapy, or immunotherapy is required.
Pathologists often use the term “positive” to describe a lymph node that contains cancer cells. For example, a lymph node that contains cancer cells may be called “positive for malignancy”.
Pathologists often use the term “negative” to describe a lymph node that does not contain any cancer cells. For example, a lymph node that does not contain cancer cells may be called “negative for malignancy”.
The pathologic stage for chondroblastic osteosarcoma is based on a system called the TNM staging system. This system is used around the world and was created by the American Joint Committee on Cancer. This system uses information about the primary tumour (T), lymph nodes (N), and distant metastatic disease (M) to determine the complete pathologic stage (pTNM). Your pathologist will give each category a number after examining your tissue sample under the microscope. In general, a higher number means more advanced disease and a worse prognosis.
For bone cancers such as chondroblastic osteosarcoma, the primary tumour (pT) stage depends on where the tumour was located in your body.
If the tumour was located in your appendicular skeleton (the bones of your arms, legs, shoulder, trunk, skull, or face), it is given a tumour stage of 1, 2 or 3 based on the size of the tumour and whether the tumour was seen in multiple parts of the bone.
If the tumour was located in your spine, it is given a tumour stage of 1, 2, 3, or 4 based on how far the tumour has grown.
If the tumour was located in your pelvis, it is given a tumour stage of 1, 2, 3, or 4 based on the size of the tumour and how far it has grown.
Primary bone cancers are given a nodal stage of 0 or 1 based on whether there are cancer cells in one or more lymph nodes.
Metastatic stage (pM)
Primary bone cancers are given a metastatic stage (pM) only if a pathologist has confirmed that tumour cells have travelled to another part of the body. They do so by examining tissue from that part of the body.
There are two metastatic stages in primary bone cancers:
Because this tissue is not typically sent to the lab, the metastatic stage cannot be determined and is not included in your report.